Billions of dollars are spent every year by pharma companies researching and testing new cancer treatments. Although there is a wealth of valuable, historical cancer clinical trial data, it’s not available. The Project Data Sphere initiative aims to change that because large pools of data can, and should, be put to use.
In February, the Faculty of 1000 (F1000) launched F1000 Research, an innovative, new open access publishing program for biology and medicine. Last week, F1000 announced the publication of F1000 Research’s first few articles .
This week, the Faculty of 1000 (F1000), announced F1000 Research, a new fully Open Access publishing program across biology and medicine that will launch later this year . F1000 Research is intended to address the major issues afflicting scientific publishing today: timely dissemination of research, peer review, and sharing of data.